Bill Anderson
American chemical engineer
Headlines and summaries are written by AI. How it works
- 2h ago
Bayer raises 2026 profit outlook as pharma offsets crop science weakness
Bayer's third-quarter adjusted EBITDA rose 6.9% to 1.615 billion euros, above analyst forecasts, and the group lifted its 2026 guidance. CEO Bill Anderson said a quick split of the company is not on the agenda.
- Oct 3
Bayer commits $2.2 billion to build pharmaceutical manufacturing plant in New Albany, Ohio
The German chemical and pharmaceutical group will create 600 jobs in New Albany, with operations slated to open in two phases between 2031 and 2034.